Skip to main content

Find Clinical Trials

Home
Conditions
Mononegavirales Infections

Clinical trial condition

Mononegavirales Infections

Explore clinical trials studying Mononegavirales Infections. Study availability and eligibility vary by location and protocol.

536 public trials 35 recruiting studies

Refine in advanced search Browse all conditions

Mononegavirales Infections trial results

Completed

Evaluating the Safety of and Immune Response to a Human Parainfluenza Virus Type 3 Ebola Virus Vaccine (HPIV3-EbovZ GP) in Healthy Adults

NCT02564575

Conditions: Filoviridae Infections, Hemorrhagic Fever, Ebola, Hemorrhagic Fevers, Viral, +4 more
Locations: Center for Immunization Research (CIR), Johns Hopkins Bloomberg School of Public Health (JHBSPH) Baltimore, Maryland, United States

View Trial Details

Completed

Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Special Drug Use Surveillance of Vaccinees After the First Vaccination

NCT02151773

Conditions: Infections, Measles, Measles/Rubella, +8 more
Locations: Not specified

View Trial Details

Completed

Safety and Immune Response to a Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children

NCT02040831

Conditions: Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations: Center for Immunization Research, JHU Baltimore, Maryland, United States

View Trial Details

Completed

A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI8897 in Healthy Adults

NCT02114268

Conditions: Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations: Research Site Overland Park, Kansas, United States

View Trial Details

Completed

Idylla IFV-RSV Panel Clinical Testing

NCT02786381

Conditions: Infections, Influenza, Human, Mononegavirales Infections, +8 more
Locations: Sacred Heart Hospital - Pensacola Pensacola, Florida, United States

View Trial Details

Completed

Efficacy and Safety of a PIKA Rabies Vaccine Containing the PIKA Adjuvant With an Accelerated Regimen

NCT02956421

Conditions: Infections, Mononegavirales Infections, RNA Virus Infections, +3 more
Locations: SingHealth Investigational Medicine Unit Singapore

Clinical Trials & Research Unit Singapore

View Trial Details

Completed

Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™

NCT00353288

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: GSK Investigational Site Ancenis, France

GSK Investigational Site Boulogne, France

GSK Investigational Site Dax, France

GSK Investigational Site Draguignan, France

View all 39 locations

View Trial Details

Completed

Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™

NCT00352898

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: GSK Investigational Site Edmonton, Alberta, Canada

GSK Investigational Site Vancouver, British Columbia, Canada

GSK Investigational Site Halifax, Nova Scotia, Canada

GSK Investigational Site Enna, Sicily, Italy

View Trial Details

Completed

Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases

NCT00127010

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: GSK Investigational Site Brussels, Belgium

GSK Investigational Site Leuven, Belgium

GSK Investigational Site Bad Saulgau, Baden-Wurttemberg, Germany

GSK Investigational Site Bönnigheim, Baden-Wurttemberg, Germany

View all 48 locations

View Trial Details

Completed

Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases

NCT00127023

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: GSK Investigational Site Bad Saulgau, Baden-Wurttemberg, Germany

GSK Investigational Site Bönnigheim, Baden-Wurttemberg, Germany

GSK Investigational Site Bretten, Baden-Wurttemberg, Germany

GSK Investigational Site Ehingen, Baden-Wurttemberg, Germany

View all 85 locations

View Trial Details